The Four-Sided Triangle of Ethics in Bioprospecting: Pharmaceutical Business, International Politics, Socio-Environmental Responsibility and the Importance of Local Stakeholders
No abstract is available for this item.
|Date of creation:||Oct 2011|
|Date of revision:|
|Contact details of provider:|| Postal: |
Web page: http://www.insper.edu.br/
More information through EDIRC
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
- Rausser, Gordon C. & Small, Arthur A., 2000.
"Valuing Research Leads: Bioprospecting and the Conservation of Genetic Resources,"
Berkeley Olin Program in Law & Economics, Working Paper Series
qt4t56m5b8, Berkeley Olin Program in Law & Economics.
- Gordon C. Rausser & Arthur A. Small, 2000. "Valuing Research Leads: Bioprospecting and the Conservation of Genetic Resources," Journal of Political Economy, University of Chicago Press, vol. 108(1), pages 173-206, February.
- Miguel e Cunha & Nuno Guimarães-Costa & Arménio Rego & Stewart Clegg, 2010. "Leading and Following (Un)ethically in Limen," Journal of Business Ethics, Springer, vol. 97(2), pages 189-206, December.
When requesting a correction, please mention this item's handle: RePEc:ibm:ibmecp:wpe_267. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Naercio Menezes)
If references are entirely missing, you can add them using this form.